Global
Anticonvulsants
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016 – 2026
Future Market Insights
www.futuremarketinsights.com
[email protected]
Report
Description
Report Description
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse
group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic
disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly
referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures.
Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition,
anticonvulsants are also used in treatment of bipolar disorder and in neuropathic pain
management.
Anyone could potentially have a single epileptic seizure at some point in their lives. This is not
the same as having epilepsy, which is a tendency to have seizures that start in the brain. Epilepsy
can affect people of any age group. Though brain injury, brain cancer, drug and alcohol misuse
and stroke are some of the reasons for epileptic seizures, the exact reason for convulsions is not
known. Some of the common symptoms which occur before convulsions include, visual loss,
strange feeling, nausea, numbness in body parts, headache and racing thoughts.
Anticonvulsants Market: Drivers and Restraints
Increasing awareness about the anticonvulsants available in the market, patent expiration of
many blockbuster drugs are some of the major factors that are driving the global anticonvulsants
market towards growth. There are now 24 antiepileptic drugs (AEDs) approved for use in
epilepsy in the US by FDA. Moreover, three trends involving consumption of AEDs have become
clinically important and must be considered by all who treat patients with epilepsy.
Report
Description
Report Description
These trends include issues of generic substitution of AEDs, pharmacogenomics predicting
serious adverse events in certain ethnic populations, and the issue of the suicide risk involving
the entire class of AEDs. While, high costs and unavailability of convenient dosage forms of both
generic and branded anticonvulsants are restraining the growth of novel therapies in the
anticonvulsants market.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb1337
Anticonvulsants Market: Segmentation
Anticonvulsants market is segmented based on product type, application, end user and
geography.
Based on product type, the anticonvulsants market is segmented as follows:
• Barbiturates
• Aldehydes
• Benzodiazepines
• Aromatic allylic alcohols
• Carboxamides
• Bromides
• Carbamates
• Sulfonamides
Report
Description
Report Description
•
•
•
•
•
•
•
•
•
•
•
•
Fructose derivatives
Pyrrolidines
Triazines
Fatty acids
Oxazolidinediones
Ureas
GABA analogs
Propionates
Hydantoins
Pyrimidinediones
Valproylamides (amide derivatives of valproate)
Others
Based on application, the anticonvulsants market is segmented as follows:
• Epilepsy
• Fibromyalgia
• Migraine
• Neuropathic pain
• Bipolar disorder
• Anxiety
• Borderline personality disorder
Report
Description
Report Description
Based on end user, the anticonvulsants market is segmented as follows:
• Hospitals
• Clinics
• Ambulatory surgical clinics
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1337
Anticonvulsants Market: Overview
Seizures are expected to result in physical, psychological and social repercussions. People with
epilepsy could adhere rigorously to their medication regimes in order to prevent these
deleterious outcomes. Treatment of epileptic seizures has led to the growth of anticonvulsants
market. Barbiturates were the first antiepileptic drugs. These are more effective and tolerable
than bromides. Hydantoins are the first to be known as modern antiepileptic drugs.
Succinimides are an old group of drug which are rarely prescribed nowadays. Consequently with
these antiepileptic or antiseizure drugs, anticonvulsants market is growing immensely leaving a
significant impact on the treatment of epileptic seizures. The antiepileptic drug market is
threatened by generic completion, which has been increasing dramatically in the face of patent
expirations among several of the major branded antiepileptics. However, there have been cases
where generic antiepileptic drugs have not been as efficacious as their branded counterparts
have.
Report
Description
Report Description
Anticonvulsants Market: Region-wise Outlook
Region wise, the global anticonvulsants marketis classified into regions namely, North America,
Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.
Currently, North America dominates the anticonvulsants market followed by Europe. Asia-Pacific
is expected to emerge as a lucrative region, owing to factors such as increasing healthcare
spending, improving healthcare infrastructure, and increasing demand for drugs. Given these
factors, the market for anticonvulsants is likely to grow rapidly in Asia-Pacific region.
Full Report Analysis@ http://www.futuremarketinsights.com/reports/anticonvulsants-market
Anticonvulsants Market: Key Players
Some of the key players, contributing to global anticonvulsants drug market, are Johnson &
Johnson (J&J), Novartis AG, UCB Group, GlaxoSmithKline plc, Pfizer Inc., Abbott Laboratories,
Cephalon Inc. and Shire plc. Pfizer has been estimated to cover the largest market share in the
antiepileptic market, accounting for close to one-third of total revenues of the market with it
two leading brands.
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research
Capabilities




Customized Research
Syndicated Research
Investment Research
Social Media Research
Sector Coverage





Automotive and Transportation

Electronics, Semiconductor, and ICT

Retail and Consumer Products

Industrial Automation and Equipment

Healthcare, Pharmaceuticals & Medical Devices
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]
Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and
Gas
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States